Barclays capital-at-risk pharma note pays 9.75% in the US

Coupons and capital risk

pharmacy-pills

Barclays in the US has issued a 12-month structured product tied to the performance of the common stock of Valeant Pharmaceuticals International. The note will pay a fixed monthly coupon even if